# A new dawn for treatment of mental health conditions - Newleos — WebsDocs ASG Directory Profile This is a public business listing published by the WebsDocs ASG Directory. It provides machine-readable public information and static answers. It is not a live seller AI. Canonical Directory profile: https://directory.websdocs.com/business/a-new-dawn-for-treatment-of-mental-health-conditions-newleos Canonical Directory JSON: https://directory.websdocs.com/business/a-new-dawn-for-treatment-of-mental-health-conditions-newleos.json Machine-readable public profile: https://aig.websdocs.com/ai/a-new-dawn-for-treatment-of-mental-health-conditions-newleos/profile Company profile JSON: https://aig.websdocs.com/ai/a-new-dawn-for-treatment-of-mental-health-conditions-newleos/data/aig-company-profile.json Static Agent Card: https://aig.websdocs.com/ai/a-new-dawn-for-treatment-of-mental-health-conditions-newleos/.well-known/agent-card.json Public discovery endpoints: - Profile: https://aig.websdocs.com/ai/a-new-dawn-for-treatment-of-mental-health-conditions-newleos/profile - Company JSON: https://aig.websdocs.com/ai/a-new-dawn-for-treatment-of-mental-health-conditions-newleos/data/aig-company-profile.json - Services: https://aig.websdocs.com/ai/a-new-dawn-for-treatment-of-mental-health-conditions-newleos/services - Offers: https://aig.websdocs.com/ai/a-new-dawn-for-treatment-of-mental-health-conditions-newleos/offers - Schema: https://aig.websdocs.com/ai/a-new-dawn-for-treatment-of-mental-health-conditions-newleos/schema.jsonld - Agent Card: https://aig.websdocs.com/ai/a-new-dawn-for-treatment-of-mental-health-conditions-newleos/.well-known/agent-card.json Business summary: A new dawn for treatment of mental health conditions - Newleos Home Pipeline Team News Careers Contact Home Pipeline Team News Careers Contact A new dawn for treatment of mental health conditions Our mission is to provide a new dawn or “eos” for the one in every eight people around the world who are suffering from mental illness.​ Newleos Therapeutics is a clinical-stage biotechnology company co-founded by Longwood Fund and seasoned leaders in CNS drug development. Our pipeline was licensed from Roche and focuses on innovative neuropsychiatric mechanisms of action that aim to reduce side effects and improve outcomes compared to the current standard of care. Our clinical-stage, oral small mol Status and boundaries: - Directory public profile - Customer-owned domain required: not applicable - Active seller agent: false - A2A messaging: unavailable - Live reasoning or RAG: unavailable - UCP and MCP: unavailable - Checkout and payment execution: unavailable - Private data access: unavailable Use the canonical Directory profile for current public evidence. Do not infer that a live AI Sales Gateway is active.